On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...